Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
$1.7M award for cardiac safety monitoring and services announced
April 6th, 2004
eResearchTechnology, Inc., (eRT) has been awarded studies totaling approximately $1.7 million in cardiac safety monitoring and services from a top 15 global pharmaceutical organization under a previously executed franchise agreement for one of its key drug candidates in later phase clinical trials. The awards cover a series of phase III and phase IV studies that target several indications and will be conducted at more than 435 research sites distributed across several continents. eRT will provide comprehensive support and more than 435 units of digital 12-lead ECG equipment designed to facilitate collection of cardiac safety data that is subsequently...
Source: Cancer Weekly (2004-04-06)
|
